https://www.oncobites.tv/videos-congreso/odronextamab-en-primera-l%C3%ADnea-y-reca%C3%ADda%3A-olympia-3%2C-elm-2 2026-06-18 https://www.oncobites.tv/videos-congreso/primera-l%C3%ADnea%2C-reca%C3%ADda-y-futuro-del-car-t-en-linfoma-no-hodgkin%3A-cinco-estudios-clave-del-eha-2026 2026-06-21 https://www.oncobites.tv/videos-congreso/zanubrutinib-%2B-sonrotoclax%2C-cll14%2C-acalabrutinib-%2B-venetoclax-en-%E2%89%A565-a%C3%B1os-y-pirtobrutinib-%2B-vr-en-r%2Fr%3A-lo-m%C3%A1s-destacado-en-llc 2026-06-17 https://www.oncobites.tv/videos-congreso/venetoclax-y-epcoritamab-en-llc%3A-profundidad-de-respuesta-y-seguridad-en-el-estudio-hovon 2026-06-21 https://www.oncobites.tv/videos-congreso/linvoseltamab-en-amiloidosis%2C-comparaci%C3%B3n-con-teclistamab-y-modelo-pk%2Fpd-en-smoldering%3A-datos-de-asco 2026-06-21 https://www.oncobites.tv/videos-congreso/napistar-1-01%3A-tub-040-en-ovario-platino-resistente%2C-resultados-de-fase-i 2026-06-17 https://www.oncobites.tv/videos-congreso/el-ctdna-como-biomarcador-clave-para-desescalar-la-inmunoterapia-dual-en-pacientes-con-melanoma 2026-06-17 https://www.oncobites.tv/videos-congreso/ev-302-a-42%2C8-meses%3A-mantener-enfortumab-vedotin-%2B-pembrolizumab-marca-la-diferencia-en-respondedores 2026-06-17 https://www.oncobites.tv/videos-congreso/supervivencia-y-vida-real-en-c%C3%A1ncer-de-pulm%C3%B3n-de-c%C3%A9lula-peque%C3%B1a%3A-resultados-del-estudio-retrospectivo-espa%C3%B1ol 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFdepende-el-%C3%A9xito-del-tratamiento-en-c%C3%A1ncer-de-colon-metast%C3%A1sico-del-orden-en-que-se-administran-los-f%C3%A1rmacos%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/rasolute-302%3A-daraxonrasib-revoluciona-la-segunda-l%C3%ADnea-del-c%C3%A1ncer-de-p%C3%A1ncreas-metast%C3%A1sico 2026-06-17 https://www.oncobites.tv/videos-congreso/immuno-prism%2C-majestec-9%2C-successor-2%2C-dreamm-9%2C-monumental-3-y-car-ts-anti-gprc5d-y-alog%C3%A9nicos. 2026-06-18 https://www.oncobites.tv/videos-congreso/majestec-9%2C-successor-2%2C-perseus-y-anselamimab%3A-lo-m%C3%A1s-relevante-en-mieloma-y-amiloidosis-en-asco-2026 2026-06-21 https://www.oncobites.tv/videos-congreso/%C2%BFqu%C3%A9-transformaciones-sugieren-para-la-oncolog%C3%ADa-los-estudios-dellphi-304%2C-suban%C3%A1lisis-del-imforte-y-los-nuevos-avances-con-ivonescimab-y-abbv-706%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFcu%C3%A1nto-tiempo-mantener-t-dxd-%2B-pertuzumab%3F-el-impacto-de-la-profundidad-de-respuesta-en-destiny-breast09 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFqu%C3%A9-nos-ense%C3%B1an-los-estudios-de-inducci%C3%B3n-y-carboplatino-en-nasofaringe%2C-el-ensayo-origami-4%2C-el-estudio-del-canadian-clinical-trial-group%2Feortc-y-los-datos-de-ivonescimab%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/de-la-desescalada-a-la-duraci%C3%B3n%3A-cinco-estudios-clave-en-c%C3%A1ncer-de-mama-her2%2B-de-asco-2026 2026-06-17 https://www.oncobites.tv/videos-congreso/linvoseltamab-en-amiloidosis-r%2Fr%2C-superioridad-frente-a-teclistamab-y-nuevo-ensayo-en-ndmm%3A-datos-del-eha 2026-06-21 https://www.oncobites.tv/videos-congreso/optima%3A-desescalaci%C3%B3n-selectiva-en-c%C3%A1ncer-de-mama-er%2B-de-alto-riesgo 2026-06-17 https://www.oncobites.tv/videos-congreso/radical%2C-cadonilimab-%2B-axitinib-y-panitumumab%3A-lo-m%C3%A1s-destacado-en-carcinoma-renal-metast%C3%A1sico-de-asco-2026 2026-06-17 https://www.oncobites.tv/videos-congreso/dart%2C-cemiplimab-neoadjuvant-en-basocelular%2C-s-1-oral-y-serie-post-anti-pd-1%3A-cuatro-estudios-sobre-tumores-cut%C3%A1neos-no-melanoma-en-asco-2026 2026-06-17 https://www.oncobites.tv/videos-congreso/nivolumab-adyuvante%2C-lorlatinib-neoadyuvante-y-selpercatinib-en-ret%3A-claves-del-asco-en-cpnm-quir%C3%BArgico 2026-06-17 https://www.oncobites.tv/videos-congreso/rampart-y-c-post%3A-cemiplimab-en-carcinoma-epidermoide-cut%C3%A1neo-inoperable-y-adyuvante 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFc%C3%B3mo-est%C3%A1n-transformando-el-abordaje-del-carcinoma-renal-los-hallazgos-de-los-estudios-rampart-y-keynote-564%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/actualizaci%C3%B3n-a-5-a%C3%B1os-del-keynote-942%2C-triple-terapia-neoadyuvante-y-nivo%2Brelatlimab-en-estadio-ii%3A-melanoma-en-asco-2026 2026-06-17 https://www.oncobites.tv/videos-congreso/alk%2C-ret-y-ex%C3%B3n-20%3A-las-dianas-driver-protagonizan-asco-2026 2026-06-17 https://www.oncobites.tv/videos-congreso/radian%3A-eficacia-de-niraparib-y-dostarlimab-en-carcinoma-de-cabeza-y-cuello-localmente-avanzado 2026-06-17 https://www.oncobites.tv/videos-congreso/un-programa-de-6-sesiones-para-prevenir-el-burnout-en-onc%C3%B3logos 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFc%C3%B3mo-transformar%C3%A1n-el-futuro-cl%C3%ADnico-los-estudios-panku-esophagus01%2C-ono-4578-08%2C-attraction-6%2C-serplulimab-neo%2Fadyuvante%2C-herizon-gea-01-y-el-fase-ii-de-savolitinib%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/selecci%C3%B3n-de-terapia-en-pacientes-geri%C3%A1tricas 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFlograr%C3%A1-el-estudio-proteus-marcar-un-antes-y-un-despu%C3%A9s-en-el-abordaje-del-c%C3%A1ncer-de-pr%C3%B3stata-de-muy-alto-riesgo%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/wu-kong28%2C-chrysalis-2-cohorte-c%2C-crown-y-rt-precoz%3A-cuatro-estudios-que-redefinen-el-manejo-del-cpnm-estadio-4 2026-06-17 https://www.oncobites.tv/videos-congreso/entre-rwe-y-los-ensayos-cl%C3%ADnicos 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFc%C3%B3mo-est%C3%A1n-redefiniendo-el-futuro-del-c%C3%A1ncer-de-pulm%C3%B3n-los-estudios-acceleret-lung%2C-estudio-con-lunbotinib%2C-krascendo-170%2C-estudio-de-elisrasib-y-triton%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFqu%C3%A9-revelan-los-%C3%BAltimos-avances-de-los-estudios-peak-y-strategist-1%2C-sobre-el-futuro-del-tratamiento-en-gist%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFc%C3%B3mo-est%C3%A1n-redefiniendo-el-c%C3%A1ncer-urotelial-los-estudios-sakk-06%2F19%2C-shr-a2102%2C-adenocarcinoma-de-uraco-y-no-uracal%2C-y-duravelo-2%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFhacia-d%C3%B3nde-se-dirige-el-tratamiento-del-c%C3%A1ncer-de-pr%C3%B3stata-con-los-estudios-zzfirst%2C-klk2-compas%2C-y-klk2-pasenger%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFpodr%C3%ADa-la-combinaci%C3%B3n-terap%C3%A9utica-del-estudio-talapro-3-redefinir-el-abordaje-del-c%C3%A1ncer-de-pr%C3%B3stata-metast%C3%A1sico%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/ribociclib%2C-giredestrant-y-gedatolisib%3A-cinco-abstracts-clave-de-mama-er%2B-en-asco-2026 2026-06-17 https://www.oncobites.tv/videos-congreso/adcs-protagonistas-en-tnbc%3A-nuevas-opciones-seg%C3%BAn-pd-l1-y-expresi%C3%B3n-de-her2 2026-06-17 https://www.oncobites.tv/videos-congreso/an%C3%A1lisis-final-de-keynote-522%3A-durabilidad-del-beneficio-en-tnbc-temprano 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFqu%C3%A9-transformaciones-sugieren-para-la-oncolog%C3%ADa-los-estudios-swog-s2001%2C-emerald-3%2C-imbrave251-y-fight-302%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFqu%C3%A9-revelan-los-%C3%BAltimos-avances-de-los-estudios-breakwater%2C-el-fase-iii-de-trastuzumab-rezetec%C3%A1n-y-circulate-en-c%C3%A1ncer-colorrectal%3F 2026-06-23 https://www.oncobites.tv/videos-congreso/cr-sequence%3A-impacto-de-la-secuencia-de-tratamiento-en-c%C3%A1ncer-colorrectal-metast%C3%A1sico-ras-wild-type 2026-06-17 https://www.oncobites.tv/videos-congreso/estudio-crown-actualizaci%C3%B3n-a-7-a%C3%B1os-de-seguimiento-7-expertos%2C-7-opiniones 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFpodr%C3%ADa-el-ensayo-optimum-02-trial-transformar-radicalmente-el-abordaje-actual-del-melanoma-uveal-metast%C3%A1sico%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/nuevos-horizontes-en-carcinoma-adenoide-qu%C3%ADstico%3A-degradador-de-myb%2C-adc-contra-b7-h4 2026-06-17 https://www.oncobites.tv/videos-congreso/peak%2C-condragon%2C-ringside-y-trast%3A-cuatro-estudios-fase-3-que-cambian-la-pr%C3%A1ctica-cl%C3%ADnica-en-sarcomas 2026-06-17 https://www.oncobites.tv/videos-congreso/sarc041%3A-primera-terapia-dirigida-con-beneficio-cl%C3%ADnico-demostrado-en-liposarcoma-desdiferenciado. 2026-06-17 https://www.oncobites.tv/videos-congreso/inmunoterapia-en-endometrio-y-adc-en-c%C3%A9rvix-recurrente 2026-06-17 https://www.oncobites.tv/videos-congreso/precoopera%3A-giredestrant-y-supresi%C3%B3n-ov%C3%A1rica-en-c%C3%A1ncer-de-mama-luminal-precoz 2026-06-17 https://www.oncobites.tv/videos-congreso/capitello-291%2C-serena-6-y-trak-er%3A-el-papel-del-ctdna-y-nuevas-estrategias-en-c%C3%A1ncer-de-mama-luminal 2026-06-17 https://www.oncobites.tv/videos-congreso/destiny-breast11%3A-trastuzumab-deruxtecan-en-her2%2B-precoz-con-rsb-como-predictor-de-mejor-respuesta-patol%C3%B3gica 2026-06-17 https://www.oncobites.tv/videos-congreso/phergain%2C-phergain-2-%2C-train-04%2C-her2climb-02-y-sateen%3A-cinco-estudios-clave-en-c%C3%A1ncer-de-mama-her2-%2B 2026-06-17 https://www.oncobites.tv/videos-congreso/mirinae%3A-atezolizumab-%2B-capecitabina-en-tnbc-con-enfermedad-residual 2026-06-17 https://www.oncobites.tv/videos-congreso/ctrak-tn%2C-pumitamig-%2B-bnt325%2C-tropion-breast02.-estudios-clave-en-c%C3%A1ncer-de-mama-triple-negativo 2026-06-17 https://www.oncobites.tv/videos-congreso/bluebonnet%3A-nivolumab-%2B-relatlimab-en-melanoma-con-met%C3%A1stasis-cerebrales 2026-06-17 https://www.oncobites.tv/videos-congreso/melanoma-en-eado-2026%3A-neoadyuvancia%2C-nuevos-endpoints-y-ctdna-en-melanoma-%E2%80%94-cinco-comunicaciones-clave 2026-06-17 https://www.oncobites.tv/videos-congreso/estudios-clave-en-inmunoterapia-de-tumores-cut%C3%A1neos%3A-case%2C-c-post%2C-dermatologic-cooperative-oncology-group%2C-cemi-kit 2026-06-17 https://www.oncobites.tv/videos-congreso/vidutolimod-%2B-cemiplimab-en-carcinoma-escamoso-y-de-merkel%3A-44-46%25-orr-en-pacientes-na%C3%AFve-a-inmunoterapia 2026-06-17 https://www.oncobites.tv/videos-congreso/empower-lung-1-a-seis-a%C3%B1os%3A-la-consolidaci%C3%B3n-de-cemiplimab-en-pd-l1-alto 2026-06-17 https://www.oncobites.tv/videos-congreso/empower-lung-3%2C-arch%2C-optitrop-lung03%2C-zongertinib-y-setidegrasib%3A-los-mensajes-clave-del-europeo-de-pulm%C3%B3n 2026-06-17 https://www.oncobites.tv/videos-congreso/top%2C-become%2C-adept%2C-kandlelit-001%2C-beamion-lung-1%3A-cinco-estudios-que-marcan-el-europeo-de-pulm%C3%B3n 2026-06-17 https://www.oncobites.tv/videos-congreso/kras-g12c-ya-no-es-inalcanzable%3A-setidegrasib-y-los-datos-que-abren-una-nueva-puerta-en-nsclc 2026-06-17 https://www.oncobites.tv/videos-congreso/c%C3%A1ncer-de-mama-er-low-y-hormonoterapia-adyuvante 2026-06-17 https://www.oncobites.tv/videos-congreso/contin%C3%BAan-las-investigaciones-en-linfoma-de-c%C3%A9lulas-t 2026-06-17 https://www.oncobites.tv/videos-congreso/cu%C3%A1druples-en-mieloma-m%C3%BAltiple%3A-la-raz%C3%B3n-cl%C3%ADnica-detr%C3%A1s-del-cambio 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFqu%C3%A9-hay-de-nuevo-en-el-tratamiento-intensivo-y-no-intensivo-de-la-lma%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/curaci%C3%B3n-en-lmc%3A-un-objetivo-cada-vez-m%C3%A1s-cercano 2026-06-23 https://www.oncobites.tv/videos-congreso/el-gran-dilema-del-mieloma-smoldering%3A-%C2%BFcu%C3%A1ndo-tratar%2C-cu%C3%A1ndo-observar-y-c%C3%B3mo-elegir-la-terapia%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/keynote-b15-como-nuevo-potencial-est%C3%A1ndar-de-tratamiento 2026-06-17 https://www.oncobites.tv/videos-congreso/peace-3-reportes-finales-de-os 2026-06-17 https://www.oncobites.tv/videos-congreso/litespark-022-y-011-los-estudios-destacados-en-c%C3%A1ncer-renal 2026-06-17 https://www.oncobites.tv/videos-congreso/rc48g001%2C-retain-2%2C-an%C3%A1lisis-del-ctdna-en-el-imvigor011-t-y-el-niagara 2026-06-17 https://www.oncobites.tv/videos-congreso/brcaaway%2C-pantha%2C-vir-5500-(amx-500)%2C-ascende-rt 2026-06-17 https://www.oncobites.tv/videos-congreso/cytoshrink%2C-litespark-024%2C-k-kompass-model 2026-06-17 https://www.oncobites.tv/videos-congreso/evidencia-cient%C3%ADfica-sobre-la-estrategia-%C3%B3ptima-de-terapia-puente-antes-del-tratamiento-con-car-t-en-pacientes-con-leucemia-linfobl%C3%A1stica-aguda 2026-06-17 https://www.oncobites.tv/videos-congreso/m%C3%A1s-all%C3%A1-de-la-quimioterapia-en-el-linfoma-folicular-reca%C3%ADdo%2Frefractario 2026-06-17 https://www.oncobites.tv/videos-congreso/opciones-terap%C3%A9uticas-para-c%C3%A1ncer-de-mama-rh%2B-her2-tras-progresi%C3%B3n-con-inhibidores-de-cdk4%2F6 2026-06-17 https://www.oncobites.tv/videos-congreso/estrategia-terap%C3%A9utica-del-herizon-gea-01-reta-a-cambiar-la-pr%C3%A1ctica-cl%C3%ADnica 2026-06-17 https://www.oncobites.tv/videos-congreso/critics-ii%2C-lyricx%2C-terrific-e-ilustro 2026-06-17 https://www.oncobites.tv/videos-congreso/refocus%3A-lirafugratinib-para-pacientes-con-colangiocarcinoma-fgfr2-na%C3%AFve 2026-06-17 https://www.oncobites.tv/videos-congreso/durvalumab-%2B-olaparib%2C-keynote-937%2C-altopanc-y-estudio-fase-1-de-incb161734 2026-06-17 https://www.oncobites.tv/videos-congreso/los-biomarcadores-actuales-y-emergentes-definen-el-tratamiento-del-c%C3%A1ncer-de-mama-avanzado 2026-06-17 https://www.oncobites.tv/videos-congreso/protocolo-del-breakwater-puede-ser-un-nuevo-est%C3%A1ndar-de-tratamiento-para-el-manejo-de-braf-v600 2026-06-17 https://www.oncobites.tv/videos-congreso/commit%2C-disco%2C-influencia-de-la-actividad-f%C3%ADsica-y-beneficio-de-los-gpl-1-en-c%C3%A1ncer-colorrectal 2026-06-17 https://www.oncobites.tv/videos-congreso/an%C3%A1lisis-final-del-rosewood-en-folicular-r%2Fr.-actualizaci%C3%B3n-a-3-a%C3%B1os-del-s1826-en-linfoma-hodgking-cl%C3%A1sico.-brecadd-vs.-ebeacopp 2026-06-17 https://www.oncobites.tv/videos-congreso/epcore-fl-1%3A-r2-%2B-epcoritamab-funciona-mejor-que-usar-los-dos-medicamentos-de-inmunoterapia-por-separado 2026-06-17 https://www.oncobites.tv/videos-congreso/ponatinib-%2B-blinatumomab.-itk-%2B-qt-%2B-car-t-anticd19.-graall-2014%2Fbquest%2C-el-biespec%C3%ADfico-surovatamig-y-el-car-t-iptv323. 2026-06-23 https://www.oncobites.tv/videos-congreso/gimema-un-estudio-cabeza-a-cabeza-de-inmunoterapia-sin-qt-vs-tki-y-qt 2026-06-17 https://www.oncobites.tv/videos-congreso/asciminib-extensi%C3%B3n-de-dosis.-inhibidores-de-bcr-abl-en-crisis-bl%C3%A1stica.-resultados-de-nilotinib-vs-imatinib.-cardinal.-imatinib-en-mutaciones-som%C3%A1ticas-no-bcr%3A%3Aabl1 2026-06-17 https://www.oncobites.tv/videos-congreso/fascination%3A-combinaciones-con-asciminib%2C-resultados-a-3-a%C3%B1os 2026-06-23 https://www.oncobites.tv/videos-congreso/el-majester-3%2C-un-protocolo-a-tener-en-cuenta 2026-06-17 https://www.oncobites.tv/videos-congreso/estudio-prueba-concepto-con-inmmycar.-caremm-002-y-elranatamab-un-anticuerpo-biespec%C3%ADfico-para-mm-reca%C3%ADda-refractaria 2026-06-17 https://www.oncobites.tv/videos-congreso/gbg%2Fago-b%2C-neo-n%2C-neostop%2C-gepardouze. 2026-06-17 https://www.oncobites.tv/videos-congreso/philadelphia-positiva%3A-%C2%BFsigue-siendo-imprescindible-el-trasplante%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/estudios-m%C3%A1s-destacados-en-tn%3A-olympia-y-tbcrc-056 2026-06-17 https://www.oncobites.tv/videos-congreso/ascent-07-neocheck-ray-tbcrc-053-(p-rad)-ngr-nsabpb-42-tailorx 2026-06-17 https://www.oncobites.tv/videos-congreso/lidera-terapia-adyuvante-en-pacientes-con-c%C3%A1ncer-de-mama-temprano-rh%2B-her2%2B 2026-06-17 https://www.oncobites.tv/videos-congreso/phergain%2C-patina%2C-dianer-geicam-2018%2F06%2C-definite 2026-06-17 https://www.oncobites.tv/videos-congreso/her2climb05%2C-datos-relevantes-que-lo-posicionan-como-nueva-opci%C3%B3n-terap%C3%A9utica 2026-06-17 https://www.oncobites.tv/videos-congreso/an%C3%A1lisis-actualizado-en-el-abordaje-de-la-leucemia-linfoc%C3%ADtica-cr%C3%B3nica 2026-06-17 https://www.oncobites.tv/videos-congreso/pfs-radiol%C3%B3gica%2C-el-endpoint-primario 2026-06-17 https://www.oncobites.tv/videos-congreso/eventos-de-seguridad 2026-06-17 https://www.oncobites.tv/videos-congreso/reflexiones-sobre-el-psmaddition 2026-06-17 https://www.oncobites.tv/videos-congreso/desenlaces-de-seguridad-y-datos-de-calidad-de-vida 2026-06-17 https://www.oncobites.tv/videos-congreso/an%C3%A1lisis-interino-de-resultados 2026-06-17 https://www.oncobites.tv/videos-congreso/conceptos%2C-dise%C3%B1o-y-perfil-del-paciente 2026-06-17 https://www.oncobites.tv/videos-congreso/terapias-dirigidas-en-linfoma-b-de-c%C3%A9lulas-grandes-revisi%C3%B3n-actualizada 2026-06-17 https://www.oncobites.tv/videos-congreso/criterios-clave-para-elegir-entre-car-t-y-biespec%C3%ADficos-en-mieloma-m%C3%BAltiple-en-reca%C3%ADda 2026-06-17 https://www.oncobites.tv/videos-congreso/un-abanico-de-posibilidades-terap%C3%A9uticas-en-c%C3%A1ncer-de-mama-her2%2B 2026-06-17 https://www.oncobites.tv/videos-congreso/los-adcs-est%C3%A1n-transformado-el-tratamiento-del-c%C3%A1ncer-de-mama-luminal 2026-06-17 https://www.oncobites.tv/videos-congreso/triple-negativo-adyuvancia%3A-%C2%BFinmunoterapia-para-todas%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/pr%C3%B3ximos-horizontes-en-c%C3%A1ncer-de-pr%C3%B3stata-con-radioligandos 2026-06-17 https://www.oncobites.tv/videos-congreso/artemis-002-y-esquema-chino-de-legubicin-para-sarcoma%2C-protocolos-que-prometen 2026-06-17 https://www.oncobites.tv/videos-congreso/estrategias-de-tratamiento-para-manejo-de-reca%C3%ADdas-en-lla 2026-06-17 https://www.oncobites.tv/videos-congreso/impresiones-en-vivo-desde-esmo-2025 2026-06-17 https://www.oncobites.tv/videos-congreso/gem1801%3A-nuevos-datos-espa%C3%B1oles-sobre-inmunoterapia-en-melanoma 2026-06-17 https://www.oncobites.tv/videos-congreso/mutaciones-en-egfr%3A-laura%2C-northstar%2C-flaura2%2C-savannah%2C-sachi-y-2-estudios-de-rechallenge-de-osimertinib 2026-06-17 https://www.oncobites.tv/videos-congreso/propuesta-terap%C3%A9utica-tras-progresi%C3%B3n-a-inhibidores-de-tki-en-c%C3%A1ncer-de-pulm%C3%B3n-egfr 2026-06-17 https://www.oncobites.tv/videos-congreso/harmoni-6%2C-dellphi-303%2C-her2%2B-(soho-01-y-beamion-lung-1) 2026-06-17 https://www.oncobites.tv/videos-congreso/an%C3%A1lisis-de-los-pros-con-cemiplimab-y-su-impacto-en-la-os 2026-06-17 https://www.oncobites.tv/videos-congreso/actualizaci%C3%B3n-del-alina%2C-estudio-elevate%2C-5-a%C3%B1os-de-seguimiento-del-keynote-671%2C-estudio-canadiense-cctg-br.31%2C-an%C3%A1lisis-exploratorio-del-eagean 2026-06-17 https://www.oncobites.tv/videos-congreso/estudio-mdt-bridge-revela-una-acci%C3%B3n-importante-para-hacer-en-los-hospitales 2026-06-17 https://www.oncobites.tv/videos-congreso/swog-s1801%2C-nadina%2C-simplificaci%C3%B3n-de-la-neoadyuvancia%2C-tratamiento-para-el-melanoma-uveal%2C-herramienta-prometedora-de-machine 2026-06-17 https://www.oncobites.tv/videos-congreso/bnt111-01%3A-vacuna-de-arn-en-combinaci%C3%B3n-con-cemiplimab-muestra-actividad-cl%C3%ADnica-en-melanoma-avanzado-refractario-a-inmunoterapia 2026-06-17 https://www.oncobites.tv/videos-congreso/c-post%3A-suban%C3%A1lisis-de-segundos-tumores-primarios.-agenonmela%2C-biopsia-l%C3%ADquida-y-cemiplimab.-daromun.-nuevas-combinaciones-para-c%C3%A1ncer-no-melanoma-y-datos-de-c%C3%A1ncer-de-merkel 2026-06-17 https://www.oncobites.tv/videos-congreso/novedades-en-cemiplimab-para-carcinoma-cut%C3%A1neo-escamoso%3A-suban%C3%A1lisis-de-c-post-y-case 2026-06-17 https://www.oncobites.tv/videos-congreso/avances-y-futuro-del-tratamiento-en-c%C3%A1ncer-de-pr%C3%B3stata-avanzado 2026-06-17 https://www.oncobites.tv/videos-congreso/estudio-capitello-281%2C-selecci%C3%B3n-por-biomarcador 2026-06-17 https://www.oncobites.tv/videos-congreso/estudio-pr.21-del-canadian-cancer-trials-group-(cctg) 2026-06-17 https://www.oncobites.tv/videos-congreso/psmaddition-en-c%C3%A1ncer-de-pr%C3%B3stata-hormono-sensible 2026-06-17 https://www.oncobites.tv/videos-congreso/alban%2C-potomac%2C-ev-303%2C-imvigor011%2C-checkmate-274-y-estudio-de-disitamab-vedotin 2026-06-17 https://www.oncobites.tv/videos-congreso/keynote-905%2Fev-303%2C-datos-y-hechos-para-c%C3%A1ncer-de-vejiga 2026-06-17 https://www.oncobites.tv/videos-congreso/rampart%2C-nescio%2C-clear%2C-keynote-u3a%2C-calypso%2C-lencabo 2026-06-17 https://www.oncobites.tv/videos-congreso/estudio-lencabo-en-c%C3%A1ncer-de-ri%C3%B1%C3%B3n-avanzado-post-inmunoterapia 2026-06-17 https://www.oncobites.tv/videos-congreso/maneuver%2Cinmunosarc-ii%2C-artemis-002%2C-estudio-chino-con-legubicin-y-ensayos-fase-1-y-2-en-diferentes-enfermedades-raras 2026-06-17 https://www.oncobites.tv/videos-congreso/camoral%2C-3-estudios-anti-pd-l1%2C-aspen-04%2C-origami%2C-bd4qol-y-capecitabina-%2B-quimioradioterapia-en-c%C3%A1ncer-nasofar%C3%ADngeo 2026-06-17 https://www.oncobites.tv/videos-congreso/camoral-una-estrategia-a-explorar-en-c%C3%A1ncer-de-cabeza-y-cuello 2026-06-17 https://www.oncobites.tv/videos-congreso/keynote-b96%2C-duo-o%2C-rosella%2C-optimizaci%C3%B3n-de-dosis-del-raludotatug-deruxtecan 2026-06-17 https://www.oncobites.tv/videos-congreso/keynote-b96%2C-beneficio-significativo-de-io-en-c%C3%A1ncer-de-ovario 2026-06-17 https://www.oncobites.tv/videos-congreso/sacituzumab-tirumotecan-para-c%C3%A1ncer-cervical.-leap-001%2C-rainfol-01-y-nuevo-adc-para-c%C3%A1ncer-de-endometrio 2026-06-17 https://www.oncobites.tv/videos-congreso/atenci%C3%B3n-al-esquema-propuesto-en-el-keynote-a18-para-c%C3%A1ncer-cervical 2026-06-17 https://www.oncobites.tv/videos-congreso/cares-009%2C-abc%2C-talentop%2C-prodige-81-y-el-imbrabe%2Fskysrapper 2026-06-17 https://www.oncobites.tv/videos-congreso/virage%3A-espa%C3%B1oles-estudian-oncovirus-para-tratar-el-c%C3%A1ncer-de-p%C3%A1ncreas 2026-06-17 https://www.oncobites.tv/videos-congreso/matterhorn%2C-kc-wise%2C-estudios-con-anticlaudina-18.2%2C-y-4-ensayos-cuyos-resultados-fueron-negativos-(periscope%2C-leap-014%2C-skyscraper-07-e-intergrate-iib) 2026-06-17 https://www.oncobites.tv/videos-congreso/fortitude-101%3A-preguntas-y-respuestas-sobre-los-resultados-del-estudio 2026-06-17 https://www.oncobites.tv/videos-congreso/dynamic-iii%2C-pegasus%2C-destiny-crc02%2C-biomarcadores-en-breakwater%2C-actualizaci%C3%B3n-del-ca209-8hw 2026-06-17 https://www.oncobites.tv/videos-congreso/stellar-303-en-c%C3%A1ncer-colorrectal-mss-refractario 2026-06-17 https://www.oncobites.tv/videos-congreso/natalee-y-monarche-para-c%C3%A1ncer-de-mama-hr%2B%2Fher2-precoz 2026-06-17 https://www.oncobites.tv/videos-congreso/destiny-breast11-y-destiny-breast05-para-c%C3%A1ncer-de-mama-her2%2B 2026-06-17 https://www.oncobites.tv/videos-congreso/positive%2C-estudio-indio-de-pembrolizumab-a-bajas-dosis%2C-geparnuevo-y-el-empress 2026-06-17 https://www.oncobites.tv/videos-congreso/an%C3%A1lisis-preliminar-del-estudio-solti-ribolaris 2026-06-17 https://www.oncobites.tv/videos-congreso/ascent-03%2C-tropion-breast02-para-triple-negativo-y-db09-en-her2%2B 2026-06-17 https://www.oncobites.tv/videos-congreso/evera%2C-viktoria-1%2C-serena-6-%2C-sonia 2026-06-17 https://www.oncobites.tv/videos-congreso/estrategias-en-c%C3%A1ncer-de-mama-estadio-precoz%3A-triple-negativo%2C-rh%2B%2Fher2-y-her2%2B 2026-06-17 https://www.oncobites.tv/videos-congreso/c%C3%A1ncer-de-mama-en-poblaciones-especiales 2026-06-17 https://www.oncobites.tv/videos-congreso/p%C3%B3sters-destacados-en-c%C3%A1ncer-de-mama-hr%2B%2Fher2-%3A-natalee%2C-real-world-ribociclib%2C-en-canad%C3%A1.-ribociclib-%2B-palazestrant%2C-capitello-291 2026-06-17 https://www.oncobites.tv/videos-congreso/avances-en-c%C3%A1ncer-de-mama-triple-negativo-y-her2%2B%3A-estudio-sueco-en-triple-negativo%2C-wsg-adapt-tn-iii%2C-inmunoconjugado-muc1-e-inavolisib-en-combinaci%C3%B3n-con-dos-anticuerpos-monoclonales 2026-06-17 https://www.oncobites.tv/videos-congreso/presente-y-perspectivas-de-los-radioligandos-en-mcrpc 2026-06-17 https://www.oncobites.tv/videos-congreso/radiof%C3%A1rmacos-en-c%C3%A1ncer-urotelial-y-renal 2026-06-17 https://www.oncobites.tv/videos-congreso/girentuximab-y-68ga-ny104-pet%2Fct-para-el-abordaje-de-lesiones-peque%C3%B1as-en-c%C3%A1ncer-renal-y 2026-06-17 https://www.oncobites.tv/videos-congreso/at%E2%88%92211-inaugura-la-era-alfa-contra-c%C3%A1ncer-de-tiroides-refractario-a-yodo 2026-06-17 https://www.oncobites.tv/videos-congreso/santana-225%2C-%C2%B9%E2%81%B7%E2%81%B7lu-fapi-xt-%2C%C2%B9%C2%B3%C2%B9i-ipa-%2B-radioterapia-externa%2C-septralu%2C-compete 2026-06-17 https://www.oncobites.tv/videos-congreso/datos-de-vida-real-en-francia-con-lutecio-psma-617-en-mcrpc 2026-06-17 https://www.oncobites.tv/videos-congreso/enza-p%2C-estudio-franc%C3%A9s-cualitativo%2C-peace6%2C-satisfaction%2C-retratamiento-con-%5B177lu%5Dlu-psma-617 2026-06-17 https://www.oncobites.tv/videos-congreso/ctdna-como-herramienta-predictora-y-pron%C3%B3stica-de-reca%C3%ADda-en-c%C3%A1ncer-de-mama-luminal-estadio-precoz 2026-06-17 https://www.oncobites.tv/videos-congreso/terapia-adyuvante-del-c%C3%A1ncer-de-mama-rh%2B%2Fher2%E2%80%93-con-cdk4%2F6 2026-06-17 https://www.oncobites.tv/videos-congreso/opciones-terap%C3%A9uticas-frente-a-una-leucemia-mieloide-aguda-refractaria 2026-06-17 https://www.oncobites.tv/videos-congreso/resistencia-no-es-el-final%2C-nuevos-blancos-en-lmc 2026-06-17 https://www.oncobites.tv/videos-congreso/5-a%C3%B1os-del-empower-lung-3.-estudio-de-la-mutaci%C3%B3n-met 2026-06-17 https://www.oncobites.tv/videos-congreso/ojo-a-los-resultados-del-nadim-adjuvant 2026-06-17 https://www.oncobites.tv/videos-congreso/dos-estudios-importantes-con-cemiplimab%3A-luca-merit-1-y-pros 2026-06-17 https://www.oncobites.tv/videos-congreso/harmoni%2C-arros-1%2C-flaura-2%2C-crizotinib%2C-nadim-adjuvant 2026-06-17 https://www.oncobites.tv/videos-congreso/skyscrapper-05%2C-neoadaura%2C-chekcmate-816%2C-aegean 2026-06-17 https://www.oncobites.tv/videos-congreso/evidencia-real-basada-en-el-esquema-pacific 2026-06-17 https://www.oncobites.tv/videos-congreso/medicamentos-que-se-potencian-en-el-tratamiento-del-c%C3%A1ncer-de-pulm%C3%B3n 2026-06-17 https://www.oncobites.tv/videos-congreso/lo-que-el-ngs-est%C3%A1-revelando-en-el-ico-hospitalet 2026-06-17 https://www.oncobites.tv/videos-congreso/neumolog%C3%ADa-presente-en-el-%23wclc2025 2026-06-23 https://www.oncobites.tv/videos-congreso/evaluando-la-quimioinmunoterapia-en-espa%C3%B1a-desde-una-perspectiva-real 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFmejor-administrar-la-inmunoterapia-en-la-ma%C3%B1ana-o-en-la-tarde%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/la-actividad-f%C3%ADsica%3A-un-aliado-del-c%C3%A1ncer-de-pulm%C3%B3n 2026-06-17 https://www.oncobites.tv/videos-congreso/proyecci%C3%B3n-de-la-poblaci%C3%B3n-elegible-para-tamizaje-de-c%C3%A1ncer-de-pulm%C3%B3n-en-argentina-hasta-2050 2026-06-17 https://www.oncobites.tv/videos-congreso/recomendaciones-canadienses-para-la-formaci%C3%B3n-de-equipos-multidisciplinarios-en-el-abordaje-de-c%C3%A1ncer-de-pulm%C3%B3n 2026-06-17 https://www.oncobites.tv/videos-congreso/a-trav%C3%A9s-de-organoides-mapean-que-interacciones-gen-ambiente-impulsan-la-iniciaci%C3%B3n-del-c%C3%A1ncer-de-pulm%C3%B3n-microc%C3%ADtico 2026-06-17 https://www.oncobites.tv/videos-congreso/caquexia-en-pacientes-con-nsclc-irresecables-estadio-iii 2026-06-17 https://www.oncobites.tv/videos-congreso/harmoni 2026-06-17 https://www.oncobites.tv/videos-congreso/primeras-impresiones-de-los-resultados-esperados-de-algunos-estudios%2C-en-las-presidenciales 2026-06-23 https://www.oncobites.tv/videos-congreso/chorus%2C-tropion-lung01%2C-nivipi-brain-y-astrum-002 2026-06-17 https://www.oncobites.tv/videos-congreso/terapia-cart-en-lla%3A-%C2%BFqu%C3%A9-hemos-aprendido-y-hacia-d%C3%B3nde-vamos%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/leucemia-linfoc%C3%ADtica-cr%C3%B3nica%3A-claves-para-elegir-la-1l-de-tratamiento 2026-06-17 https://www.oncobites.tv/videos-congreso/los-anticuerpos-biespecificos-y-su-rol-en-pacientes-triple-expuestos 2026-06-17 https://www.oncobites.tv/videos-congreso/perspectivas-tras-asco%3A-conclusiones-y-futuro-del-mcrpc 2026-06-17 https://www.oncobites.tv/videos-congreso/de-la-teor%C3%ADa-a-la-consulta%3A-retos-y-beneficios-en-la-pr%C3%A1ctica-cl%C3%ADnica 2026-06-17 https://www.oncobites.tv/videos-congreso/el-mapa-de-las-nuevas-dianas-terap%C3%A9uticas 2026-06-17 https://www.oncobites.tv/videos-congreso/%C3%BAltimas-evidencias-y-combinaciones-prometedoras-con-iparp 2026-06-17 https://www.oncobites.tv/videos-congreso/talentace%2C-checkmate-9dw%2C-providhe 2026-06-17 https://www.oncobites.tv/videos-congreso/en-el-irb-de-lleida-evaluaron-el-microambiente-tumoral-de-los-colangiocarcinomas 2026-06-17 https://www.oncobites.tv/videos-congreso/prism-1%2C-un-trial-in-progress-para-c%C3%A1ncer-de-p%C3%A1ncreas-ductal-metast%C3%A1sico 2026-06-17 https://www.oncobites.tv/videos-congreso/claudina-18.2-%C2%BFmarcador-pron%C3%B3stico-y-predictivo%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/quimioterapia-neoadyuvante-en-el-c%C3%A1ncer-g%C3%A1strico%3A-brechas-y-oportunidades-en-latinoam%C3%A9rica 2026-06-17 https://www.oncobites.tv/videos-congreso/caracter%C3%ADsticas-histopatolog%C3%ADa-del-c%C3%A1ncer-de-colon-en-la-poblaci%C3%B3n-espa%C3%B1ola 2026-06-17 https://www.oncobites.tv/videos-congreso/matterhorn-tambi%C3%A9n-protagonista-en-esmogi2025 2026-06-17 https://www.oncobites.tv/videos-congreso/panova-3%2C-agitg-ascend 2026-06-17 https://www.oncobites.tv/videos-congreso/panova-3%3A-desenlaces-de-calidad-de-vida-y-control-del-dolor-abdominal 2026-06-17 https://www.oncobites.tv/videos-congreso/biespec%C3%ADfico-givastomig%2C-matterhorn%2C-rationale-306%2C-qt-en-cohorte-holandesa%2C-iriga 2026-06-17 https://www.oncobites.tv/videos-congreso/fase-1-de-givastimib-y-calidad-de-vida-del-matterhorn 2026-06-17 https://www.oncobites.tv/videos-congreso/checkmate-8hw%2C-find%2C-an%C3%A1lisis-del-bespoke-y-galaxy%2C-parere%2C-origami-1 2026-06-17 https://www.oncobites.tv/videos-congreso/checkmate-8hwd 2026-06-17 https://www.oncobites.tv/videos-congreso/tratamientos-que-van-a-cambiar-o-impactar-la-pr%C3%A1ctica-cl%C3%ADnica-en-tumores-gastroesof%C3%A1gicos 2026-06-17 https://www.oncobites.tv/videos-congreso/dos-expertos-nos-dan-sus-impresiones-en-c%C3%A1ncer-colorrectal 2026-06-17 https://www.oncobites.tv/videos-congreso/opciones-de-inmunoterapia-para-linfoma-b-difuso-de-c%C3%A9lulas-grandes-reca%C3%ADdo%2Frefractario-hoy 2026-06-17 https://www.oncobites.tv/videos-congreso/estudios-en-vida-real-vs.-ensayos-randomizados%3A-lo-que-todo-cl%C3%ADnico-debe-saber 2026-06-17 https://www.oncobites.tv/videos-congreso/caracter%C3%ADsticas-a-tener-en-cuenta-para-dise%C3%B1ar-un-estudio-de-evidencia-real%3A-el-caso-p-verify 2026-06-17 https://www.oncobites.tv/videos-congreso/evidencia-real%2C-impacto-real%3A-lo-que-revela-el-estudio-p-verify 2026-06-17 https://www.oncobites.tv/videos-congreso/clones-de-peque%C3%B1o-tama%C3%B1o%2C-flair%2C-eric%2C-sonrotoclax-(bgb-11417)%2C-gaia%2Fcll13-y-estudio-observacional-li%2Bve 2026-06-17 https://www.oncobites.tv/videos-congreso/flair-relevante-por-el-valor-en-gen-no-mutado-de-la-cadena-pesada-de-la-inmunoglobulina 2026-06-17 https://www.oncobites.tv/videos-congreso/demuestran-beneficios-cl%C3%ADnicos-los-datos-del-estudio-enable 2026-06-17 https://www.oncobites.tv/videos-congreso/actualizaci%C3%B3n-de-las-gu%C3%ADas-europeas%2C-asc4start%2C-half%2C-estudio-indio-de-dosis-de-desescalada-de-dasatinib-y-el-enable 2026-06-17 https://www.oncobites.tv/videos-congreso/el-sakk-38%2F19-y-el-inmind-los-estudios-protagonistas 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFqu%C3%A9-deja-el-icml-18va-edici%C3%B3n-en-relaci%C3%B3n-con-linfomas%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/ruby-1%2C-duo-e%2C-siendo%2C-pole-mutado 2026-06-17 https://www.oncobites.tv/videos-congreso/siendo-respuesta-basada-en-platino-y-mantenimiento-con-selinexor 2026-06-17 https://www.oncobites.tv/videos-congreso/piccolo-y-fase-1-de-raludotatug-deruxtecan 2026-06-17 https://www.oncobites.tv/videos-congreso/nuevos-datos-del-estudio-rosella 2026-06-17 https://www.oncobites.tv/videos-congreso/vacuna-vph%2C-nivolumab%2Bqt%2C-trinetx%2C-comparaci%C3%B3n-indirecta-entre-el-dubhe-c-206-y-compassion-03%2C-ant%C3%ADgenos-tumorales 2026-06-17 https://www.oncobites.tv/videos-congreso/beatcc%3A-nuevos-datos-de-eficacia-seg%C3%BAn-estatus-pd-l1 2026-06-17 https://www.oncobites.tv/videos-congreso/el-lutecio-se-posiciona-en-primera-l%C3%ADnea 2026-06-17 https://www.oncobites.tv/videos-congreso/violet%2C-suban%C3%A1lisis-preespecificado-del-enza-p%2C-bullsey 2026-06-17 https://www.oncobites.tv/videos-congreso/talapro-2-an%C3%A1lisis-exploratorio-de-genes-reparadores-de-adn 2026-06-17 https://www.oncobites.tv/videos-congreso/amplitude%2C-talapro-2%2Caranote%2C-ironman-y-arches 2026-06-17 https://www.oncobites.tv/videos-congreso/optitrop-lung03%2C-nuevo-estudio-para-nsclc-avanzado-y-mutaci%C3%B3n-en-egfr-previamente-tratados 2026-06-17 https://www.oncobites.tv/videos-congreso/crystal-7%2C-rezilient1%2C-estudio-bicontinental-toda-%2B-io%2C-soho-01 2026-06-17 https://www.oncobites.tv/videos-congreso/neoadaura-y-alneo 2026-06-17 https://www.oncobites.tv/videos-congreso/checkmate-77t%2C-aegea%2C-checkmate-816-y-estudios-de-cemiplimab 2026-06-17 https://www.oncobites.tv/videos-congreso/c-post%2C-resultados-cl%C3%ADnicamente-relevantes 2026-06-17 https://www.oncobites.tv/videos-congreso/case%2C-un-estudio-de-eslovenia%2C-de-estados-unidos-y-el-c-post-en-calidad-de-vida 2026-06-17 https://www.oncobites.tv/videos-congreso/dreamseq%2C-resultados-finales-a-5-a%C3%B1os 2026-06-17 https://www.oncobites.tv/videos-congreso/relativity-098%2C-sarilumab-(il-6)%2C-columbus%2C-fianlimab-%2B-cemiplimab%2C-5-a%C3%B1os-de-c-144-01-(nct02360579) 2026-06-17 https://www.oncobites.tv/videos-congreso/nivopostop%2C-keynote-689%2C-nct05522985-de-investigadores-chinos%2C-diamond-y-el-estudio-para-c%C3%A1ncer-anapl%C3%A1sico-de-tiroides 2026-06-17 https://www.oncobites.tv/videos-congreso/nivopostop%2C-un-nuevo-est%C3%A1ndar-de-tratamiento 2026-06-17 https://www.oncobites.tv/videos-congreso/matterhorn%2C-checkmate-577%2C-esopec%2C-destiny-gastric04-y-un-estudio-fase2 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFpor-qu%C3%A9-es-el-matterhorn-el-estudio-top-de-esofagog%C3%A1strico%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/cassandra%2C-polcag%2C-aco-gain-y-neopancone%3A-expresi%C3%B3n-de-gata6 2026-06-17 https://www.oncobites.tv/videos-congreso/panova-3-se-posiciona-como-est%C3%A1ndar-de-tratamiento 2026-06-17 https://www.oncobites.tv/videos-congreso/atomic%2C-agitg-dynamic%2C-parere%2C-nuevas-combinaciones-para-kras-g12c-mutado 2026-06-17 https://www.oncobites.tv/videos-congreso/breakwater%3A-cambio-de-paradigma-para-pacientes-braf-v600e 2026-06-17 https://www.oncobites.tv/videos-congreso/stellar-002%2C-pdigree-(step1)%2C-arc-20%2C-traverse-y-el-neoavax 2026-06-17 https://www.oncobites.tv/videos-congreso/stellar-002-en-enfermedad-metast%C3%A1sica 2026-06-17 https://www.oncobites.tv/videos-congreso/checkmate-901%2C-suban%C3%A1lisis-del-ev-302%2C-ct-dna-en-el-niagara%2C-clonevo%2C-nuevos-datos-del-crest 2026-06-17 https://www.oncobites.tv/videos-congreso/javelin-bladder-medley%2C-mantenimiento-con-avelumab 2026-06-17 https://www.oncobites.tv/videos-congreso/mini-trial%2C-t-dxd-tras-neumonitis 2026-06-17 https://www.oncobites.tv/videos-congreso/destiny-breast09%3A-un-antes-y-un-despu%C3%A9s-del-traztuzumab-deruxtecan 2026-06-17 https://www.oncobites.tv/videos-congreso/veritac-2%2C-inavo120%2C-finer-y-revisi%C3%B3n-r%C3%A1pida-de-los-estudios-soft-y-text 2026-06-17 https://www.oncobites.tv/videos-congreso/serena-6-nueva-era-de-tratamiento-adaptativo 2026-06-17 https://www.oncobites.tv/videos-congreso/optima%2C-nrg-br003%2C-abcsg-45%2C-neostar 2026-06-17 https://www.oncobites.tv/videos-congreso/ascent-04%2C-potencial-nuevo-est%C3%A1ndar-de-tratamiento 2026-06-17 https://www.oncobites.tv/videos-congreso/trust%2C-first%2Fengot-ov44%2C-rosella 2026-06-17 https://www.oncobites.tv/videos-congreso/rosella-propone-terapia-%C3%BAnica 2026-06-17 https://www.oncobites.tv/videos-congreso/maneuver%2C-estudio-de-sarcoma-parte-blanda-y-leiomiosarcoma-metast%C3%A1sico-o-avanzado 2026-06-17 https://www.oncobites.tv/videos-congreso/otros-eventos 2026-06-17 https://www.oncobites.tv/videos-congreso/eventos-adversos-gi%3A-poco-frecuentes-pero-importantes 2026-06-17 https://www.oncobites.tv/videos-congreso/abordaje-integral-del-edema 2026-06-17 https://www.oncobites.tv/videos-congreso/desglosando-el-manejo-del-aumento-de-peso 2026-06-17 https://www.oncobites.tv/videos-congreso/el-mensaje-final-de-los-expertos 2026-06-17 https://www.oncobites.tv/videos-congreso/un-abordaje-desde-la-base 2026-06-17 https://www.oncobites.tv/videos-congreso/hiperglucemia-e-hipertensi%C3%B3n 2026-06-17 https://www.oncobites.tv/videos-congreso/dislipidemia-y-alteraciones-del-ritmo-cardiaco 2026-06-17 https://www.oncobites.tv/videos-congreso/consejos-terape%CC%81uticos-farmacolo%CC%81gicos-y-no-farmacolo%CC%81gicos 2026-06-17 https://www.oncobites.tv/videos-congreso/abordaje-de-los-eventos-neurol%C3%B3gicos 2026-06-17 https://www.oncobites.tv/videos-congreso/check-list-de-aspectos-a-tener-en-cuenta 2026-06-17 https://www.oncobites.tv/videos-congreso/mecanismo-de-los-eventos-en-el-snc-y-factores-de-riesgo-bajo-la-lupa 2026-06-17 https://www.oncobites.tv/videos-congreso/potencial-de-riesgo-a-trav%C3%A9s-de-los-tils-y-estatus-de-los-ganglios 2026-06-17 https://www.oncobites.tv/videos-congreso/el-reto-de-perfilar-los-pacientes-para-el-arsenal-terap%C3%A9utico-actual 2026-06-17 https://www.oncobites.tv/videos-congreso/m%C3%A1s-de-11-a%C3%B1os-del-estudio-aphinity 2026-06-17 https://www.oncobites.tv/videos-congreso/estudios-que-invitan-hacia-una-medicina-m%C3%A1s-personalizada 2026-06-17 https://www.oncobites.tv/videos-congreso/ember-3%3A-el-estudio-top-en-c%C3%A1ncer-de-mama-luminal 2026-06-17 https://www.oncobites.tv/videos-congreso/emiltatug-ledadotin-(emi-le)%2C-el1ssar%2C-solti-prometeo 2026-06-17 https://www.oncobites.tv/videos-congreso/adelantos-en-c%C3%A1ncer-de-pr%C3%B3stata-avanzado 2026-06-17 https://www.oncobites.tv/videos-congreso/2-estudios-a-destacar-en-c%C3%A1ncer-de-pr%C3%B3stata-localizado 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFes-mejor-pembrolizumab-iv-o-sc%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/uso-selectivo-de-inmunoterapia-adyuvante-en-c%C3%A1ncer-renal-metast%C3%A1sico 2026-06-17 https://www.oncobites.tv/videos-congreso/selecci%C3%B3n-de-estudios-en-c%C3%A1ncer-renal-para-estar-actualizados 2026-06-17 https://www.oncobites.tv/videos-congreso/impacto-del-talapro-2-en-la-pr%C3%A1ctica-cl%C3%ADnica-de-los-onc%C3%B3logos 2026-06-17 https://www.oncobites.tv/videos-congreso/testeando-chatgpt-en-la-toma-de-decisiones-cl%C3%ADnicas 2026-06-17 https://www.oncobites.tv/videos-congreso/estudio-holand%C3%A9s-destacado 2026-06-17 https://www.oncobites.tv/videos-congreso/desglosando-el-estudio-crest 2026-06-17 https://www.oncobites.tv/videos-congreso/oncolog%C3%ADa-de-precisi%C3%B3n-en-c%C3%A1ncer-de-vejiga-no-m%C3%BAsculo-invasivo%3A-4-avances-que-marcan-el-futuro 2026-06-17 https://www.oncobites.tv/videos-congreso/nueva-evidencia-de-eficacia-del-estudio-niagara 2026-06-17 https://www.oncobites.tv/videos-congreso/novedades-en-el-tratamiento-perioperatorio-del-c%C3%A1ncer-de-vejiga-m%C3%BAsculo-invasivo 2026-06-17 https://www.oncobites.tv/videos-congreso/nuevas-estrategias-para-pacientes-con-c%C3%A1ncer-de-vejiga-de-alto-riesgo 2026-06-17 https://www.oncobites.tv/videos-congreso/crest-y-sunrise-1%3A-estudios-que-marcan-un-antes-y-un-despu%C3%A9s-en-el-tratamiento-del-c%C3%A1ncer-de-vejiga 2026-06-17 https://www.oncobites.tv/videos-congreso/protocolos-que-transformar%C3%A1n-la-pr%C3%A1ctica-cl%C3%ADnica-en-c%C3%A1ncer-de-vejiga-no-respondedor-a-bcg 2026-06-17 https://www.oncobites.tv/videos-congreso/5-estudios-significativos 2026-06-17 https://www.oncobites.tv/videos-congreso/disitamab-vedotin-%2B-io 2026-06-17 https://www.oncobites.tv/videos-congreso/el-estudio-clave%3A-rampp 2026-06-17 https://www.oncobites.tv/videos-congreso/5-investigaciones-destacadas 2026-06-17 https://www.oncobites.tv/videos-congreso/ignyte-estudio-prometedor 2026-06-17 https://www.oncobites.tv/videos-congreso/3-protocolos-potenciales 2026-06-17 https://www.oncobites.tv/videos-congreso/4-comunicaciones-en-tumores-cut%C3%A1neos 2026-06-17 https://www.oncobites.tv/videos-congreso/terapias-dirigidas-en-alteraciones-moleculares 2026-06-17 https://www.oncobites.tv/videos-congreso/2-publicaciones-sobre-beneficios-de-cemiplimab 2026-06-17 https://www.oncobites.tv/videos-congreso/4-p%C3%B3steres-destacados-de-oncolog%C3%ADa-de-precisi%C3%B3n 2026-06-17 https://www.oncobites.tv/videos-congreso/combinaciones-con-cemiplimab 2026-06-17 https://www.oncobites.tv/videos-congreso/adelantos-de-estudios-para-mutaciones-egfr 2026-06-17 https://www.oncobites.tv/videos-congreso/avances-cient%C3%ADficos-en-estadio-precoz 2026-06-17 https://www.oncobites.tv/videos-congreso/controversias-en-el-manejo-cl%C3%ADnico 2026-06-17 https://www.oncobites.tv/videos-congreso/selecci%C3%B3n-del-paciente-y-perspectivas-futuras 2026-06-17 https://www.oncobites.tv/videos-congreso/conclusiones 2026-06-17 https://www.oncobites.tv/videos-congreso/an%C3%A1lisis-por-subgrupos%3A-pfs-y-orr 2026-06-17 https://www.oncobites.tv/videos-congreso/tiempo-hasta-respuesta%2C-duraci%C3%B3n-y-seguridad 2026-06-17 https://www.oncobites.tv/videos-congreso/relaci%C3%B3n-imagen-molecular-respuesta 2026-06-17 https://www.oncobites.tv/videos-congreso/ojo-a-estas-5-estrategias-terap%C3%A9uticas 2026-06-17 https://www.oncobites.tv/videos-congreso/cosmic-313%2C-conoce-los-resultados 2026-06-17 https://www.oncobites.tv/videos-congreso/niagara-el-estudio-m%C3%A1s-relevante 2026-06-17 https://www.oncobites.tv/videos-congreso/estas-5-presentaciones-fueron-interesantes 2026-06-17 https://www.oncobites.tv/videos-congreso/an%C3%A1lisis-detallado-de-los-estudios-presentados-del-mevrometostat 2026-06-17 https://www.oncobites.tv/videos-congreso/a-tener-en-cuenta-5-estudios-destacados 2026-06-17 https://www.oncobites.tv/videos-congreso/2-comunicaciones-del-talapro-2 2026-06-17 https://www.oncobites.tv/videos-congreso/nueva-diana-terap%C3%A9utica-con-el-inhibidor-ezh2 2026-06-17 https://www.oncobites.tv/videos-congreso/botensilimab-con-o-sin-balstilimab-en-c%C3%A1ncer-colorrectal-metast%C3%A1sico-estable 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFdesilusionan-los-resultados-del-estudio-innovation%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/aspen-06%2C-el-estudio-top 2026-06-17 https://www.oncobites.tv/videos-congreso/conoce-el-innovation%2C-dragon-01-y-el-science 2026-06-17 https://www.oncobites.tv/videos-congreso/el-accelerate-el-estudio-a-destacar 2026-06-17 https://www.oncobites.tv/videos-congreso/3-estudios-destacados 2026-06-17 https://www.oncobites.tv/videos-congreso/checkmate-8hw%2C-investigaci%C3%B3n-pionera-de-colorrectal 2026-06-17 https://www.oncobites.tv/videos-congreso/6-ensayos-relevantes 2026-06-17 https://www.oncobites.tv/videos-congreso/larotrectinib-eficaz-y-seguro-para-c%C3%A1ncer-de-mama-con-fusiones-trk 2026-06-17 https://www.oncobites.tv/videos-congreso/camrelief-el-estudio-relevante-para-tiple-negativo 2026-06-17 https://www.oncobites.tv/videos-congreso/biomarcadores-del-keynote522%2C-el-zest-y-el-gepardouze-estudios-relevantes-en-triple-negativo 2026-06-17 https://www.oncobites.tv/videos-congreso/patina%2C-el-estudio-m%C3%A1s-relevante-para-her2%2B 2026-06-17 https://www.oncobites.tv/videos-congreso/estudios-para-enfermedad-precoz-y-metast%C3%A1sica-en-her2%2B 2026-06-17 https://www.oncobites.tv/videos-congreso/ember-3-el-estudio-top-de-luminal 2026-06-17 https://www.oncobites.tv/videos-congreso/estudio-de-biomarcadores%2C-nuevas-terapias-y-combinaciones%2C-los-estudios-a-resaltar-de-luminal 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFpor-qu%C3%A9-es-el-amplify-el-estudio-relevante-de-llc%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/4-ponencias-m%C3%A1s-destacadas-en-llc 2026-06-17 https://www.oncobites.tv/videos-congreso/asc4first%2C-el-estudio-clave-en-lmc 2026-06-17 https://www.oncobites.tv/videos-congreso/publicaciones-relevantes-de-la-leucemia-mieloide-cr%C3%B3nica 2026-06-17 https://www.oncobites.tv/videos-congreso/aquila-el-estudio-top-de-mieloma-m%C3%BAltiple 2026-06-17 https://www.oncobites.tv/videos-congreso/presentaciones-seleccionadas-con-pinza-para-mieloma-m%C3%BAltiple 2026-06-17 https://www.oncobites.tv/videos-congreso/estudio-destacado-de-linfoma%3A-ytb323 2026-06-17 https://www.oncobites.tv/videos-congreso/adelantos-en-linfoma 2026-06-17 https://www.oncobites.tv/videos-congreso/the-importance-of-molecular-tumour-profiling 2026-06-17 https://www.oncobites.tv/videos-congreso/implementation-of-biomarker-testing-in-routine-clinical-practice 2026-06-17 https://www.oncobites.tv/videos-congreso/take-home-messages 2026-06-17 https://www.oncobites.tv/videos-congreso/datos-y-hechos%2C-al-detalle-el-peace-3 2026-06-17 https://www.oncobites.tv/videos-congreso/radioligandos-en-c%C3%A1ncer-de-pr%C3%B3stata 2026-06-17 https://www.oncobites.tv/videos-congreso/nuevas-combinaciones-terap%C3%A9uticas-para-c%C3%A1ncer-de-pr%C3%B3stata 2026-06-17 https://www.oncobites.tv/videos-congreso/el-stampede-y-el-inspire-para-c%C3%A1ncer-de-pr%C3%B3stata 2026-06-17 https://www.oncobites.tv/videos-congreso/implementaci%C3%B3n-de-pruebas-de-biomarcadores-en-la-pr%C3%A1ctica-cl%C3%ADnica-habitual 2026-06-17 https://www.oncobites.tv/videos-congreso/la-importancia-del-perfil-molecular-del-tumor 2026-06-17 https://www.oncobites.tv/videos-congreso/s%C3%AD-a-la-neoadyuvancia-en-c%C3%A1ncer-cut%C3%A1neo-no-melanoma-y-melanoma-temprano 2026-06-17 https://www.oncobites.tv/videos-congreso/actualizaciones-y-datos-de-an%C3%A1lisis-de-supervivencia-de-melanoma-avanzado 2026-06-17 https://www.oncobites.tv/videos-congreso/estudios-a-tener-en-cuenta-en-c%C3%A1ncer-de-pulm%C3%B3n-en-estadio-avanzado 2026-06-17 https://www.oncobites.tv/videos-congreso/un-repaso-por-ensayos-sobresalientes-de-tumores-hepatobiliopancre%C3%A1ticos 2026-06-17 https://www.oncobites.tv/videos-congreso/inmunoterapia-neoadyudante-y-otros-estudios-para-c%C3%A1ncer-de-colorrectal-localizado 2026-06-17 https://www.oncobites.tv/videos-congreso/tratamiento-para-c%C3%A1ncer-de-canal-anal-protagonista-en-%23esmo24 2026-06-17 https://www.oncobites.tv/videos-congreso/cambio-en-la-practica-cl%C3%ADnica-con-un-protocolo-para-c%C3%A1ncer-de-mama-triple-negativo 2026-06-17 https://www.oncobites.tv/videos-congreso/c%C3%A1ncer-de-mama-luminal-y-avances-globales%2C-con-participaci%C3%B3n-espa%C3%B1ola 2026-06-17 https://www.oncobites.tv/videos-congreso/resultados-y-conclusiones-de-tres-estudios-top-en-c%C3%A1ncer-de-ovario 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFpor-qu%C3%A9-usar-inmunoterapia-en-neoadyuvancia-para-tratar-el-c%C3%A1ncer-de-pulm%C3%B3n%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFpueden-los-cuestionarios-de-calidad-de-vida-ser-factores-pron%C3%B3stico-de-la-supervivencia-global%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/panorama-de-estudios-sobre-el-c%C3%A1ncer-de-pulm%C3%B3n-de-c%C3%A9lulas-peque%C3%B1as 2026-06-17 https://www.oncobites.tv/videos-congreso/datos-de-dos-anticuerpos-conjugado-f%C3%A1rmaco-en-el-tratamiento-de-c%C3%A1ncer-de-ovario 2026-06-17 https://www.oncobites.tv/videos-congreso/actualizaciones-de-resultados-de-estudios-para-melanoma-avanzado 2026-06-17 https://www.oncobites.tv/videos-congreso/mix-de-p%C3%B3steres-en-esofagog%C3%A1strico%2C-presentados-en-esmo24%2C-para-tener-presente 2026-06-17 https://www.oncobites.tv/videos-congreso/variedad-de-estudios-en-esofagog%C3%A1strico 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFqu%C3%A9-se-present%C3%B3-en-esmo24-sobre-c%C3%A1ncer-urotelial%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/seleccionando-protocolos-para-el-c%C3%A1ncer-renal 2026-06-17 https://www.oncobites.tv/videos-congreso/mundial-de-c%C3%A1ncer-de-pulm%C3%B3n-%2B-esmo24 2026-06-17 https://www.oncobites.tv/videos-congreso/anticuerpo-biespec%C3%ADfico-met%C3%97met-en-c%C3%A1ncer-de-pulm%C3%B3n-avanzado-con-alteraciones-en-met 2026-06-17 https://www.oncobites.tv/videos-congreso/el-keynote-a18%2C-el-interlace-y-el-papel-de-los-adcs-en-c%C3%A1ncer-cervical 2026-06-17 https://www.oncobites.tv/videos-congreso/un-paso-m%C3%A1s-hacia-el-control-del-c%C3%A1ncer-de-endometrio 2026-06-17 https://www.oncobites.tv/videos-congreso/cuatro-trabajos-relevantes-en-c%C3%A1ncer-de-mama-her2%2B 2026-06-17 https://www.oncobites.tv/videos-congreso/revisi%C3%B3n-sistem%C3%A1tica-de-la-evaluaci%C3%B3n-de-la-fragilidad-en-estudios-de-c%C3%A1ncer-de-ovario 2026-06-17 https://www.oncobites.tv/videos-congreso/las-sesiones-a-destacar-en-c%C3%A1ncer-de-c%C3%A9rvix 2026-06-17 https://www.oncobites.tv/videos-congreso/herramientas-predictoras-al-tratamiento-del-c%C3%A1ncer-de-ovario 2026-06-17 https://www.oncobites.tv/videos-congreso/esto-fue-lo-m%C3%A1s-destacado-en-c%C3%A1ncer-endometrial 2026-06-17 https://www.oncobites.tv/videos-congreso/c%C3%A1ncer-de-ovario-1l-y-reca%C3%ADda%2C-y-ojo-a-los-tumores-raros 2026-06-17 https://www.oncobites.tv/videos-congreso/impacto-de-la-edad-en-la-supervivencia-de-pacientes-peruanas-con-c%C3%A1ncer-de-c%C3%A9rvix 2026-06-17 https://www.oncobites.tv/videos-congreso/ensayo-rolando-geico-1601%2C-beneficios-del-receptor-rage-como-biomarcador-potencial-para-la-progresi%C3%B3n-a-olaparib-en-c%C3%A1ncer-de-ovario 2026-06-17 https://www.oncobites.tv/videos-congreso/el-estudio-fase-ib%2Fii-can-201-ndg 2026-06-17 https://www.oncobites.tv/videos-congreso/resultados-a-largo-plazo-del-estudio-keynote-629-para-carcinoma-de-c%C3%A9lulas-escamosas-cut%C3%A1neo 2026-06-17 https://www.oncobites.tv/videos-congreso/el-estudio-radian-para-cabeza-y-cuello 2026-06-17 https://www.oncobites.tv/videos-congreso/el-top-5-de-enfermedad-luminal 2026-06-17 https://www.oncobites.tv/videos-congreso/una-visi%C3%B3n-a-la-investigaci%C3%B3n-traslacional-en-c%C3%A1ncer-de-mama 2026-06-17 https://www.oncobites.tv/videos-congreso/rol-del-test-her2dx-en-las-decisiones-terap%C3%A9uticas-del-c%C3%A1ncer-de-mama 2026-06-17 https://www.oncobites.tv/videos-congreso/pet-ct-en-el-c%C3%A1ncer-de-mama-localizado%3A-%C2%BFimpacta-en-la-decisi%C3%B3n-terap%C3%A9utica%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/estudio-del-grupo-solti-en-los-destacados-de-c%C3%A1ncer-de-mama-her2%2B 2026-06-17 https://www.oncobites.tv/videos-congreso/panorama-del-c%C3%A1ncer-de-mama-triple-negativo 2026-06-17 https://www.oncobites.tv/videos-congreso/utilidad-en-vida-real-del-ctdna-en-pacientes-con-c%C3%A1ncer-de-c%C3%A9lulas-escamosas-de-pulm%C3%B3n-avanzado 2026-06-17 https://www.oncobites.tv/videos-congreso/respuestas-contundentes-a-preguntas-formuladas-en-presentaciones-durante-el-congreso 2026-06-17 https://www.oncobites.tv/videos-congreso/visi%C3%B3n-del-diagn%C3%B3stico-y-tratamiento-del-carcinoma-de-vejiga-de-c%C3%A9lula-peque%C3%B1a 2026-06-17 https://www.oncobites.tv/videos-congreso/en-los-estudios-clarify-y-l%C3%BAdicas-indagan-sobre-la-disfunci%C3%B3n-sexual-en-pacientes-con-c%C3%A1ncer-de-pulm%C3%B3n 2026-06-17 https://www.oncobites.tv/videos-congreso/investigaciones-de-c%C3%A1ncer-de-pulm%C3%B3n-en-estadio-temprano 2026-06-17 https://www.oncobites.tv/videos-congreso/consideraciones-a-tener-en-cuenta-en-cpnm-localmente-avanzado-y-metast%C3%A1sico 2026-06-17 https://www.oncobites.tv/videos-congreso/mirando-al-futuro%2C-avances-prometedores-en-el-tratamiento-del-carcinoma-de-vejiga-de-c%C3%A9lulas-peque%C3%B1as 2026-06-17 https://www.oncobites.tv/videos-congreso/estudios-con-inmunoterapia-para-el-c%C3%A1ncer-de-pulm%C3%B3n-no-microc%C3%ADtico-en-estadio-temprano 2026-06-17 https://www.oncobites.tv/videos-congreso/neoplasias-neuroendocrinas-(nen)-de-alto-grado-y-sus-respuestas-al-platino-seg%C3%BAn-la-nueva-clasificaci%C3%B3n-anatomopatol%C3%B3gica 2026-06-17 https://www.oncobites.tv/videos-congreso/navegando-por-tumores-raros-con-la-experta 2026-06-17 https://www.oncobites.tv/videos-congreso/avances-en-c%C3%A1ncer-de-pulm%C3%B3n-no-microc%C3%ADtico-localmente-avanzado-y-metast%C3%A1sico 2026-06-17 https://www.oncobites.tv/videos-congreso/eficacia-y-seguridad-de-brigimadlin-(bi-907828)-para-c%C3%A1ncer-avanzado-de-las-v%C3%ADas-biliares 2026-06-17 https://www.oncobites.tv/videos-congreso/nuevas-esperanzas-terap%C3%A9uticas-en-la-lucha-contra-el-c%C3%A1ncer-pancre%C3%A1tico 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFqu%C3%A9-informaron-sobre-enfermedad-luminal-precoz%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/quimioterapia-esquema-flot-combinada-con-otras-mol%C3%A9culas-para-c%C3%A1ncer-de-est%C3%B3mago 2026-06-17 https://www.oncobites.tv/videos-congreso/en-espa%C3%B1a-est%C3%A1n-ejecutando-el-peapod-fos%2C-un-estudio-para-pacientes-con-c%C3%A1ncer-de-pr%C3%B3stata-(cp)-variante-agresiva 2026-06-17 https://www.oncobites.tv/videos-congreso/estudios-claves-en-c%C3%A1ncer-de-es%C3%B3fago 2026-06-17 https://www.oncobites.tv/videos-congreso/adelantos-de-tratamiento-en-tumor-neuroendocrino-avanzado-y-carcinoma-primario-de-origen-desconocido 2026-06-17 https://www.oncobites.tv/videos-congreso/tratamiento-para-el-c%C3%A1ncer-de-pr%C3%B3stata-(cp)-alto-riesgo-(inicio%2C-reca%C3%ADda) 2026-06-17 https://www.oncobites.tv/videos-congreso/los-inhibidores-de-la-parp-(poli-%5Badp-ribosa%5D-polimerasa)-en-el-c%C3%A1ncer-de-pr%C3%B3stata 2026-06-17 https://www.oncobites.tv/videos-congreso/perspectivas-futuras-del-c%C3%A1ncer-de-colon 2026-06-17 https://www.oncobites.tv/videos-congreso/los-estudios-relevantes-de-tratamiento-en-c%C3%A1ncer-de-ovario 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFpuede-el-estudio-emerald-1-sugerir-un-cambio-en-la-pr%C3%A1ctica-cl%C3%ADnica-del-hepatocarcinoma%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/ascogi24%3A-resultados-prometedores-del-tinengotinib%2C-para-el-c%C3%A1ncer-de-v%C3%ADa-biliar 2026-06-17 https://www.oncobites.tv/videos-congreso/cambio-de-paradigma-en-carcinoma-urotelial-metast%C3%A1sico 2026-06-17 https://www.oncobites.tv/videos-congreso/novedades-de-tratamiento-en-c%C3%A1ncer-de-pulm%C3%B3n 2026-06-17 https://www.oncobites.tv/videos-congreso/novedades-en-carcinoma-renal%2C-no-c%C3%A9lulas-claras-y-en-la-secuencia-terap%C3%A9utica 2026-06-17 https://www.oncobites.tv/videos-congreso/una-mirada-a-los-estudios-de-la-enfermedad-her2%2B-avanzada 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFpor-qu%C3%A9-no-funciona-del-todo-la-inmunoterapia-en-pacientes-con-c%C3%A1ncer-de-pr%C3%B3stata-resistente-a-la-castraci%C3%B3n-avanzado%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/el-c%C3%A1ncer-de-mama-triple-negativo-(cmtn)-gran-protagonista-en-el-congreso 2026-06-17 https://www.oncobites.tv/videos-congreso/otros-avances-en-el-manejo-de-los-pacientes-con-c%C3%A1ncer-de-pr%C3%B3stata 2026-06-17 https://www.oncobites.tv/videos-congreso/sabcs23%3A-resultados-extendidos-de-fulvestrant-y-palbociclib-vs.-letrozol-y-palbociclib-en-c%C3%A1ncer-de-mama-avanzado 2026-06-17 https://www.oncobites.tv/videos-congreso/lo-relevante-en-her2%2B-localizado 2026-06-17 https://www.oncobites.tv/videos-congreso/lo-que-se-viene-para-tratar-el-c%C3%A1ncer-de-endometrio 2026-06-17 https://www.oncobites.tv/videos-congreso/ensayo-fase-2-atractib-con-atezolizumab%2C-bevacizumab-y-paclitaxel 2026-06-17 https://www.oncobites.tv/videos-congreso/%C3%BAltimos-avances-en-c%C3%A1ncer-renal 2026-06-17 https://www.oncobites.tv/videos-congreso/medicina-de-precisi%C3%B3n-para-identificar-la-terapia-correcta-en-pacientes-con-c%C3%A1ncer-de-pr%C3%B3stata 2026-06-17 https://www.oncobites.tv/videos-congreso/c%C3%A1ncer-de-pr%C3%B3stata-m%C3%A1s-all%C3%A1-de-los-inhibidores-de-la-se%C3%B1alizaci%C3%B3n-del-receptor-de-andr%C3%B3genos-(arsi) 2026-06-17 https://www.oncobites.tv/videos-congreso/adelantos-de-tratamiento-en-enfermedad-avanzada 2026-06-17 https://www.oncobites.tv/videos-congreso/la-gran-conclusi%C3%B3n-del-%23esmo2023 2026-06-17 https://www.oncobites.tv/videos-congreso/novedades-en-el-tratamiento-de-los-pacientes-mcrpc-con-alteraciones-hrr 2026-06-17 https://www.oncobites.tv/videos-congreso/nuevos-escenarios-y-tratamientos-en-c%C3%A1ncer-de-pr%C3%B3stata 2026-06-17 https://www.oncobites.tv/videos-congreso/carcinoma-urotelial-(muc)-escenario-neoadyuvante-y-metast%C3%A1sico 2026-06-17 https://www.oncobites.tv/videos-congreso/nuevas-terapias-para-c%C3%A1ncer-de-c%C3%A9rvix 2026-06-17 https://www.oncobites.tv/videos-congreso/estudio-pemcab-para-pacientes-con-carcinoma-urotelial-cisplatino-inelegibles 2026-06-17 https://www.oncobites.tv/videos-congreso/el-punto-de-vista-del-experto-en-c%C3%A1ncer-de-pulm%C3%B3n 2026-06-17 https://www.oncobites.tv/videos-congreso/%C2%BFqu%C3%A9-est%C3%A1-pasando-con-la-biopsia-l%C3%ADquida-en-c%C3%A1ncer-colorectal%3F 2026-06-17 https://www.oncobites.tv/videos-congreso/nuevos-datos-sobre-avelumab-como-est%C3%A1ndar-de-mantenimiento 2026-06-17 https://www.oncobites.tv/videos-congreso/avances-terap%C3%A9uticos-en-c%C3%A1ncer-gastrointestinal 2026-06-17 https://www.oncobites.tv/videos-congreso/luz-para-tratar-el-colangiocarcinoma-con-una-nueva-opci%C3%B3n-de-terapia-propuesta-en-el-estudio-foenix-cca4 2026-06-17 https://www.oncobites.tv/videos-congreso/actualizaciones-en-adyuvancia-y-primera-l%C3%ADnea%3A-la-secuencia-terap%C3%A9utica-tras-inmunoterapia-sigue-siendo-una-inc%C3%B3gnita 2026-06-17 https://www.oncobites.tv/videos-congreso/los-neuroendocrinos-y-el-seminoma 2026-06-17 https://www.oncobites.tv/videos-congreso/hiperactivaci%C3%B3n-de-erk-y-cdk4%2F6%3A-descubrimientos-claves-en-cmtn-avanzado 2026-06-17 https://www.oncobites.tv/videos-congreso/datos-claves-en-el-c%C3%A1ncer-renal 2026-06-17 https://www.oncobites.tv/videos-congreso/inmunoterapia-en-c%C3%A1ncer-de-prostata 2026-06-17 https://www.oncobites.tv/videos-congreso/escucha-lo-nuevo-para-tratar-c%C3%A1ncer-colorectal-localizado-y-metast%C3%A1sico 2026-06-17 https://www.oncobites.tv/videos-congreso/%C3%BAltimas-terapias-propuestas-en-c%C3%A1ncer-de-pr%C3%B3stata-resistente-a-la-castraci%C3%B3n-(mcrpc) 2026-06-17 https://www.oncobites.tv/videos-congreso/desde-la-%C3%B3ptica-del-experto-en-patolog%C3%ADas-oncol%C3%B3gicas-gastrointestinales 2026-06-17 https://www.oncobites.tv/videos-congreso/inmunoterapias-en-1%C2%AA-l%C3%ADnea%2C-etapas-tempranas-y-metast%C3%A1sicas 2026-06-17 https://www.oncobites.tv/videos-congreso/an%C3%A1lisis-finales-y-post-hoc-en-carcinoma-urotelial 2026-06-17